
NewcelX Ltd.
NewcelX Ltd. (NCEL)
Price
Market cap
Next catalystPlanned Phase 1/2a commencement in Q2 2027, subject to applicable regulatory requirements; November guidance restates 2027NCEL-101 with tegoprubart — planned Phase 1/2a · Trial initiationSEC filing ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved
Other pipelines
Approved / commercial
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved